Eli Lilly & Co recalls ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by: ImClone LLC
Recalled November 21, 2018 · FDA recall D-0248-2019 · Eli Lilly &
Hazard
Labeling: Missing label; potential for missing primary container label on the vial. · FDA Class III
Units
9,380 vials
Sold at
AL, AZ, CA, KS, LA, MS, OH, OR, TN, TX and Puerto Rico
Description
Labeling: Missing label; potential for missing primary container label on the vial.
Product
ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by: ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, Branchburg, NJ 08876 USA. NDC: 66733-958-23
Manufacturer(s)
Eli Lilly & Co
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →